What percentage of copper peptides actually works?

GHK is a naturally occurring tripeptide that binds copper with an affinity similar to the copper-transport site on albumin, forming GHK-Cu. In a rat experimental wound model, researchers found that GHK-Cu produced a concentration-dependent increase in dry weight, total protein, collagen, elastin, and glycosaminoglycans in the wound tissue, along with elevated collagen and TGF-beta mRNA — genuine evidence that 'more copper peptide' can mean 'more connective-tissue-building signal,' at least in an injured-tissue model. The honest limitation: this is a wound-repair model in rats, using a copper peptide delivered directly into a wound chamber, not a topical cosmetic formulation applied to intact human facial skin. It tells you the mechanism can scale with dose; it doesn't tell you what percentage does the most for your skin in a jar.

• Study In rat wound chambers, GHK-Cu produced a concentration-dependent increase in dry weight, total protein, collagen, elastin and glycosaminoglycans, with elevated collagen and TGF-beta mRNAs. ¹
• Review GHK has a copper(II) affinity similar to the copper-transport site on albumin and forms GHK-Cu, the complex that activates remodeling-related processes including cell chemoattraction, anti-inflammatory action, and matrix-protein synthesis. ²

The Cosmetic Ingredient Review Expert Panel's safety assessment of tripeptide-1, hexapeptide-12, their metal salts (which includes copper tripeptide-1 / GHK-Cu) and fatty acyl derivatives found these ingredients are safe as used in cosmetics, and specifically noted typical use concentrations below 10 parts per million — that's 0.001%, a fraction of a percent. That figure reflects historical formulation practice for peptides broadly, where signal peptides are dosed in the parts-per-million range because they're expensive, potent-in-vitro actives. Contrast that with what's on shelves now: The Ordinary's 'Multi-Peptide + Copper Peptides 1%' discloses copper tripeptide-1 at a full 1% — a thousand times the CIR's typical-use figure — and it's not an outlier; copper-peptide-focused serums from NIOD and smaller independent brands are formulated in a similar higher-percentage range. No published human trial has tested whether the modern 1% tier delivers meaningfully more facial benefit than the historical trace-level tier, or whether it's simply what current formulators believe (without a specific RCT to confirm) makes a more compelling, differentiated product.

• CIR The CIR Expert Panel concluded that tripeptide-1, hexapeptide-12, their metal salts (including copper tripeptide-1) and fatty acyl derivatives are safe as used in cosmetics, specifically noting typical use concentrations below 10 parts per million and absence of sensitization signals. ³

One honest caveat No published human RCT compares a trace-level (parts-per-million) copper peptide formulation against a modern 1% formulation on facial skin outcomes. The 1% figure comes from product INCI disclosure, not from a clinical dose-finding study.

A handful of current products disclose their copper-peptide percentage directly rather than leaving it buried in an undifferentiated ingredient list. The Ordinary's Multi-Peptide + Copper Peptides 1% names its concentration in the product title, verified in the INCI as copper tripeptide-1 present alongside a broader peptide stack (Matrixyl, Argireline, SYN-AKE). Asterwood's Copper Peptides Serum and NIOD's Copper Amino Isolate Serum both build their formulas around GHK-Cu as the headline active, though their exact percentages aren't stated in the same explicit way. None of this settles the concentration question — it just shows that 1% has become a de facto marketing and formulation benchmark in the current copper-peptide category, distinct from the trace levels the CIR safety data describes.

What percentage of copper peptides is effective?

There's no validated answer from human clinical trials. The CIR safety review notes typical historical cosmetic use of copper tripeptide-1 at under 10 parts per million (0.001%) (DOI:10.1177/1091581818807863), while modern serums like The Ordinary's disclose 1% — a thousand times more. A rat wound model found GHK-Cu's tissue-building effect was concentration-dependent (PMID:8227353), but no study has tested different percentages against each other on human facial skin. ³¹

Is 1% copper peptides better than a lower percentage?

Plausibly, based on the preclinical dose-response signal in wound tissue, but it hasn't been tested directly on facial skin. The 1% figure that appears in current product names and formulas is roughly a thousand times higher than the CIR's typical historical use concentration, and no published RCT confirms that jump translates into a proportionally bigger cosmetic benefit. ¹³

Why do copper peptide products vary so much in stated percentage?

Because there's no regulatory or clinical standard forcing consistency. Some brands, like The Ordinary, put the percentage in the product name (Multi-Peptide + Copper Peptides 1%); others, like NIOD's Copper Amino Isolate Serum or Asterwood's Copper Peptides Serum, build the formula around GHK-Cu without stating an exact percentage. Historical cosmetic-safety data (CIR) describes typical use at under 10 ppm, while current marketing has normalized 1% as a benchmark — the category is still working out what number matters. ³

Is a high concentration of copper peptides safe?

The CIR Expert Panel concluded that copper tripeptide-1 and related peptides are safe as used in cosmetics, based on data reflecting typical (lower, ppm-range) use concentrations. Modern 1% formulations haven't triggered a distinct safety review of their own, but copper peptides as a class have a long, well-tolerated history. As always, copper peptides are traditionally kept apart from high-dose vitamin C and strong direct acids in the same step, regardless of percentage, to protect the copper complex. ³

Does a higher percentage mean more visible results?

Reasonable to assume given the preclinical dose-response data, but not proven. The wound-chamber study showing concentration-dependent collagen and elastin accumulation was conducted in rats with GHK-Cu delivered into a wound, not applied topically to intact human facial skin in a percentage-controlled trial. Treat any specific percentage claim on a copper-peptide product as a formulation choice rather than a clinically validated dose. ¹

1. 1

   In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds

   Maquart FX, Bellon G, Chaqour B, et al · J Clin Invest 92(5):2368-76 · 1993

2. 2

   The human tri-peptide GHK and tissue remodeling

   Pickart L · J Biomater Sci Polym Ed 19(8):969-88 · 2008

3. 3

   Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics

   Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B · International Journal of Toxicology 37(3 suppl):90S-102S · 2018